Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine

European Journal of Pharmacology

Volumn 584, Issue 1, 2008, Pages 49-56

  Feng, Mei ^a   Liu, Lihua ^a   Guo, Zheng ^a   Xiong, Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Lysophosphatidylcholine; Nitric oxide; Nitric oxide synthase

Indexed keywords

DIMETHYLARGININASE; DIMETHYLARGININASE 2; LYSOPHOSPHATIDYLCHOLINE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL;

AMIDOHYDROLASES; ARGININE; CELL LINE, TRANSFORMED; CELL SURVIVAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; ENZYME REPRESSION; HUMANS; LYSOPHOSPHATIDYLCHOLINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 41149102802     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.01.029     Document Type: Article

References (36)

1. Achan V., Tran C.T., Arrigoni F., Whitley G.S., Leiper J.M., and Vallance P. All-trans-retinoic acid increases nitric oxide synthesis by endothelial cells. A role for the induction of dimethylarginine dimethylaminohydrolase. Circ. Res. 90 (2002) 764-769
2. Barsanti J.A., and Duncan J.R. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal. Biochem. 79 (1977) 544-552
3. Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., and Cooke J.P. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation. 98 (1998) 1842-1847
4. Böger R.H., Bode-Böger S.M., Sydow K., Heistad D.D., and Lentz S.R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1557-1564
5. Böger R.H., Sydow K., Borlak J., Thum T., Lenzen H., Schubert B., Tsikas D., and Bode-Boger S.M. LDL cholesterol upregulates synthesis of asymmetric dimethylarginine (ADMA) in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 87 (2000) 99-105
6. Chen Y., Li Y., Zhang P., Traverse J.H., Hou M., Xu X., Kimoto M., and Bache R.J. Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts. Am. J. Physiol. Heart Circ. Physiol. 289 (1997) H2212-H2219
7. Cooke J.P., and Dzau V.J. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96 (1997) 379-382
8. Cowan C.L., and Steffen R.P. Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 2290-2297
9. Dayoub H., Achan V., Adimoolam S., Jacobi J., Stuehlinger M.C., Wang B.Y., et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108 (2003) 3042-3047
10. Deng H.F., and Xiong Y. Effects of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta. Acta Pharmacol. Sin. 26 (2005) 92-98
11. Fu Y.F., Xiong Y., and Guo Z. A reduction of endogenous asymmetric dimethylarginine contributes to the effects of captopril on the endothelial dysfunction induced by homocysteine in rats. Eur. J. Pharmacol. 508 (2005) 167-175
12. Holden D.P., Cartwright J.E., Nussey S.S., and Whitley G.S. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580
13. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., and Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
14. Jiang J.L., Li N.S., Li Y.J., and Deng H.W. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br. J. Pharmacol. 135 (2002) 1175-1182
15. Jiang D.J., Jiang J.L., Tan G.S., Du Y.H., Xu K.P., and Li Y.J. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Naunyn-Schmiedebergs Arch. Pharmakol. 367 (2003) 600-606
16. Kikuta K., Sawamura T., Miwa S., Hashimoto N., and Masaki T. High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. Circ. Res. 83 (1998) 1088-1096
17. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., and Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoprotein. Nature 344 (1990) 160-162
18. Leiper J.M., Santa M.J., Chubb A., MacAllister R.J., Charles I.G., Whitley G.S., and Vallance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 343 (1999) 209-214
19. MacAllister R.J., Fickling S.A., Whitley G.S., and Vallance P. Metabolism of methylarginines by human vasculature: implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol. 112 (1994) 43-48
20. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R.J., Hodson H., Whitley G.S., and Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119 (1996) 1533-1540
21. Mangin Jr. E.L., Kugiyama K., Nguy J.H., Kerns S.A., and Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on relaxation of rabbit aorta. Circ. Res. 72 (1993) 161-166
22. Miyazaki H., Matsuoka H., Cooke J.P., Usui M., Ueda S., Okuda S., and Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99 (1999) 1141-1146
23. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 (2001) 88-97
24. Ohara Y., Peteson T.E., Zheng B., Kuo J.F., and Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler. Thromb. Vasc. Biol. 14 (1994) 1007-1013
25. Sorrenti V., Mazza F., Campisi A., Vanella L., Li Volti G., and Di Giacomo C. High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr. Neurovasc. Res. 3 (2006) 49-54
26. Tarpey M.M., and Fridovich I. Methods of detection of vascular reactive species nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89 (2001) 224-236
27. Tsao P.S., McEvoy L.M., Drexler H., Butcher E.C., and Cooke J.P. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 89 (1994) 2176-2182
28. Tyagi N., Collins K., Steed M.M., Ovechkin A.V., Moshal K.S., and Tyagi S.C. Mechanisms of homocysteine-induced oxidative stress. Am. J. Physiol., Heart Circ. Physiol. 289 (2005) H2649-H2656
29. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet 339 (1992) 572-575
30. Xiong Y., Li Y.J., Yu X.J., Liu G.Z., and Li N.S. Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits. Acta Pharmacol. Sin. 17 (1996) 149-152
31. Xiong Y., Lu R., Li Y.J., and Deng H.W. Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum. Acta Pharmacol. Sin. 18 (1997) 511-514
32. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., and Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28 (2001) 842-847
33. Xiong Y., Lei M.X., Fu S.H., and Fu Y.F. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci. 77 (2005) 149-159
34. Yin Q.F., Fu S.H., He P., and Xiong Y. Dimethylarginine dimethylaminohydrolase inhibition and Asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Atherosclerosis 190 (2007) 53-61
35. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesion of rabbit and man. J. Clin. Invest. 84 (1989) 1086-1095
36. Yu X.J., Li Y.J., and Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life. Sci. 54 (1994) 753-758